The FTC filed a complaint against AbbVie and Teva Pharmaceutical alleging the companies illegally blocked American consumers’ access to lower-cost versions of the testosterone replacement therapy AndroGel.

http://www.bizjournals.com/chicago/news/2014/09/09/ftc-sues-abbvie-teva-over-testosterone-replacement.html